Open-source ecosystem for in vitro and microphysiological systems
Save the DateDecember 1-2, 2026Charlotte, North Carolina12th Annual Regenerative Manufacturing Innovation Consortium (RegMIC) Meeting: A Roadmap for Tissue Organoids and Body-on-a-Chip Manufacturing Standards

Open ecosystem for organoids, chips, and microphysiological systems

PhysioVerse: accelerating open innovation for advanced in vitro and microphysiological systems

PhysioVerse connects people, datasets, tools, workflows, standards exchange, training, and translational pathways for organoids, body-on-chip systems, tissue chips, and related microphysiological systems. The goal is to reduce fragmentation and help the field move toward reproducible, interoperable, and widely adoptable approaches.

PhysioVerse Data FinderStatus: In training / progress
PhysioVerse MPS EngineStatus: In training / progress

What PhysioVerse enables

Core capabilities that support a professional open ecosystem

PhysioVerse helps teams discover, contribute, align, and translate advanced in vitro and microphysiological system resources through shared infrastructure.

Exemplar reusable media

Making organoid images and videos reusable for downstream AI/ML

PhysioVerse can connect visual data such as microscopy images and beating organoid videos with structured metadata, biological context, provenance, assay descriptors, and contributor credits. This makes exemplar datasets easier to find, compare, curate, and prepare for downstream AI/ML training.

14-day cardiac organoids

14-day cardiac organoids differentiated from the same human induced pluripotent stem cells. Bright field video shows synchronized beating at approximately 60 bpm.

14-day liver organoid with albumin and vimentin staining

14-day liver organoid

14-day liver organoid made from a mixture of primary liver cells. The red staining (albumin) shows albumin being produced from the hepatocytes and the green staining (vimentin) indicates the presence of hepatic stellate cells.

26-day cerebral organoid staining panels

26-day cerebral organoid

26-day cerebral brain organoid differentiated from human induced pluripotent stem cells. The left panel shows large cavities morphologically similar to ventricles, lined with stratified epithelium. The right panel shows vimentin-positive neuroprogenitor cells and Sox2-positive neural stem cells.

For further information, see these related records:

Learn more

Explore the PhysioVerse overview

Open the sections below for a deeper look at the mission, value, and participation paths within the PhysioVerse open ecosystem.

What is PhysioVerse?

PhysioVerse is an open ecosystem for organoids, body-on-chip systems, tissue chips, organ tissue equivalents, and related microphysiological systems. It connects people, datasets, tools, workflows, standards exchange, training, and translational pathways so the field can move toward reproducible, interoperable, and widely adoptable approaches.

Why does PhysioVerse matter?

Society is at a critical juncture, relying on limited methods and animal testing to develop transformative technology. For a field that is attempting to evolve rapidly, this has created barriers and fragmentation has impeded innovation and access to new therapies. We are in search of bold pioneers to help create ground-breaking approaches that improve human and animal health.

Through the development and adoption of organoids and body-on-chip systems, also known as microphysiological systems, the field can:

  • Improve toxicity assessments of drugs, cosmetics, pesticides, and environmental exposures in more human-relevant systems.
  • Reduce reliance on animal models by creating alternatives and complements to traditional animal models.
  • Expand understanding of biological pathways and support more accurate disease models.
  • Screen drug candidates earlier for effectiveness and safety signals before later-stage development.
  • Capture patient-specific biology and support progress toward translational applications.
  • Improve organ transplantation outcomes and strengthen translation to patient and animal health.
What makes PhysioVerse an open-source ecosystem?

An open-source ecosystem depends on more than a code repository. PhysioVerse provides an innovation platform for people and organizations to curate specialty datasets, validate, benchmark, search datasets, develop models, submit files, improve metadata practices, contribute to tool development, review submissions for enhancements, support and receive training, and help institutions adopt shared workflows.

This platform helps communities reduce fragmentation and improve reproducibility, discovery, manufacturing, shipping and storage, analytical capabilities, and translation for organoid, chip-based, and related advanced model systems. This work contributes to standards, interoperability, workforce development, economic development, and translation through partnerships with the NSF Regenerative Medicine Engine in North Carolina, WFIRM, MOSSDO, and RegMIC.

Who participates in PhysioVerse?

PhysioVerse is designed for users, data contributors, tool developers, curators, researchers, industry partners, institutions, training teams, standards contributors, and translational stakeholders. Each group can participate in a practical way: discovering data, submitting resources, improving metadata, contributing tools, joining learning activities, reviewing submissions, or helping institutions adopt shared workflows.

How can I get started?

Start with the On-Ramp if you are new to the ecosystem. Use the Data Library to discover resources, choose Contribute to submit data or metadata, explore Tools and GitHub for technical resources, or visit Community and News and Events to join activities and follow updates.

Where should I start?

Choose the path that matches what you want to do

PhysioVerse connects users to the right entry point, whether they want to find data, contribute resources, use tools, align metadata, join the community, or learn how to participate.

Model spotlight

A human-relevant in vitro model example

The airway organ tissue equivalent (OTE)-on-a-chip model is one example of how advanced in vitro and microphysiological systems can mimic important features of the human airway. By recreating tissue organization and dynamic airway behavior, models like this can support disease studies, exposure studies, toxicity assessment, drug discovery, and more human-relevant research while helping reduce reliance on animal models.

Annotated airway organ tissue equivalent showing cilia, bronchial epithelial cells, fibroblast cells, and extracellular matrix
Airway tissue organization
Dynamic airway behavior

Why data compatibility matters

Models like this can improve drug discovery, strengthen safety testing, reduce reliance on animal models, and help accelerate better therapies. Their value grows when imaging, omics, and other data modalities can be interpreted, compared, and reused across studies instead of remaining isolated within individual laboratories.

That is why an open-source ecosystem like PhysioVerse is needed. PhysioVerse helps connect in vitro and microphysiological system data with shared metadata, model descriptors, protocols, assay outputs, file relationships, and review workflows. By making these data more standardized and discoverable, PhysioVerse can help the community compare models across laboratories, build confidence in results, support regulatory and translational use, and move the field toward more reproducible and human-relevant science.

News and Events

Updates, learning opportunities, and community activities

Follow platform updates, workshops, release notes, standards activities, training opportunities, and ways to participate in PhysioVerse.

Participate in PhysioVerse

Help build shared resources for advanced model systems

Join as a user, data contributor, tool developer, curator, training contributor, industry partner, institutional participant, or translational stakeholder.